Showing 31,261 - 31,280 results of 52,749 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((nn decrease) OR (mean decrease)) ))', query time: 1.28s Refine Results
  1. 31261

    Data_Sheet_1_Cerebral Oxygenation During Neonatal Intubation–Ancillary Study of the Prettineo–Study.PDF by Meryl Vedrenne-Cloquet (6415619)

    Published 2019
    “…The two primary outcomes were a decrease in rScO<sub>2</sub> value >20% from baseline and a decrease in fractional cerebral tissue oxygen extraction (FTOE) value >10% from baseline, at any time point. …”
  2. 31262

    Image_1_Cerebral Oxygenation During Neonatal Intubation–Ancillary Study of the Prettineo–Study.TIFF by Meryl Vedrenne-Cloquet (6415619)

    Published 2019
    “…The two primary outcomes were a decrease in rScO<sub>2</sub> value >20% from baseline and a decrease in fractional cerebral tissue oxygen extraction (FTOE) value >10% from baseline, at any time point. …”
  3. 31263

    Table_1_Metabolic Profiling of Cognitive Aging in Midlife.DOCX by Zhiguang Huo (785658)

    Published 2020
    “…Results in twins showed that higher baseline levels of four plasma metabolites, including sphingomyelin (d18:1/20:1 and d18:2/20:0), sphingomyelin (d18:1/22:1, d18:2/22:0, and d16:1/24:1), DAG (18:2/20:4), and hydroxy-CMPF, were significantly associated with a slower decrease in one or more domains of cognitive function. …”
  4. 31264
  5. 31265

    Proliferation of HBO-treated cells. by Jennifer Schulze (2502799)

    Published 2017
    “…By contrast, the proliferation of MSCs started to decrease after five consecutive HBO treatments with 2.0 bar until the end of ten treatments in comparison to NOR. …”
  6. 31266
  7. 31267
  8. 31268
  9. 31269
  10. 31270
  11. 31271

    Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection - Fig 2 by Victoria Therese Mücke (5979356)

    Published 2018
    “…<p><b>Course of (A) sphingosine, (B) sphinganine, (C) sphinganine-1-phosphate, (D) C16-dihydroceramide (C16DHC), (E) C18- and (F) C20-ceramide (C18/C20Cer) in patients with no virologic events from baseline (BL) over a follow-up (FU) period of four years (1–4).…”
  12. 31272
  13. 31273

    The biphasic effect of emodepside on hum KCNMA1 currents. by Anna Crisford (803573)

    Published 2015
    “…Arrow indicates the time of emodepside application at <b>A</b>. 1nM <b>B</b>. 10nM and <b>C</b>. 100nM. Data points are the mean ± s.e.mean. 100nM emodepside had a biphasic effect on hum KCNMA1 currents eliciting a significant increase between 4 and 8 min application (p<0.05) and a significant decrease after 20 min application (p<0.001); two-way ANOVA with Bonferroni post-hoc tests.…”
  14. 31274
  15. 31275
  16. 31276
  17. 31277

    ReFus GS vs. PS files by Eric Butoto (11923394)

    Published 2022
    “…We observed similar cumulative responses to GS and PS, representing decreases of about 50% of mean FER and FUM compared to the base population. …”
  18. 31278

    Blocking K<sub>Ca</sub>3.1 with TRAM-34 and ICA-17043 induces a dose-dependent attenuation of myofibroblast wound healing. by Katy Morgan Roach (504094)

    Published 2013
    “…There was a dose-dependent decrease in FBS-induced wound healing over 48h in the presence of either <b>a</b>) TRAM-34 (20 nM and 200 nM) (<i>P</i><0.0001, repeated measures ANOVA) or <b>b</b>) ICA-17043 (10 nM and 100 nM) (<i>P</i>=0.0095, repeated measures ANOVA). …”
  19. 31279
  20. 31280